BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors. 2019

Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China.

Histone lysine-specific demethylase 1 (LSD1) was the first discovered histone demethylase. Inactivating LSD1 or downregulating its expression inhibits cancer-cell development, and thus, it is an attractive molecular target for the development of novel cancer therapeutics. In this study, we worked on the structural optimization of natural products and identified 30 novel LSD1 inhibitors. Utilizing a structure-based drug design strategy, we designed and synthesized a series of curcumin analogues that were shown to be potent LSD1 inhibitors in the enzyme assay. Compound WB07 displayed the most potent LSD1 inhibitory activity, with an IC50 value of 0.8 μM. Moreover, WA20 showed an anticlonogenic effect on A549 cells with an IC50 value of 4.4 μM. Molecular docking simulations were also carried out, and the results indicated that the inhibitors bound to the protein active site located around the key residues of Asp555 and Asp556. These findings suggested that compounds WA20 and WB07 are the first curcumin analogue-based LSD1 inhibitors with remarkable A549 suppressive activity, providing a novel scaffold for the development of LSD1 inhibitors.

UI MeSH Term Description Entries
D003474 Curcumin A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-,Curcumin Phytosome,Diferuloylmethane,Mervia,Turmeric Yellow,Phytosome, Curcumin,Yellow, Turmeric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D056466 Histone Demethylases Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism. Histone Demethylase,Histone Lysine Demethylase,Histone Arginine Demethylases,Histone Lysine Demethylases,Arginine Demethylases, Histone,Demethylase, Histone,Demethylase, Histone Lysine,Demethylases, Histone,Demethylases, Histone Arginine,Demethylases, Histone Lysine,Lysine Demethylase, Histone,Lysine Demethylases, Histone
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors.
February 2022, Archiv der Pharmazie,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation.
January 2017, European journal of medicinal chemistry,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Synthesis and biological evaluation of unsymmetrical curcumin analogues as tyrosinase inhibitors.
April 2013, Molecules (Basel, Switzerland),
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis and biological evaluation of bambuterol analogues as novel inhibitors of butyrylcholinesterase.
January 2017, European journal of medicinal chemistry,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.
February 2016, European journal of medicinal chemistry,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
October 2016, European journal of medicinal chemistry,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis, and evaluation of curcumin analogues as potential inhibitors of bacterial sialidase.
December 2018, Journal of enzyme inhibition and medicinal chemistry,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis and biological evaluation of tasiamide analogues as tumor inhibitors.
April 2014, Marine drugs,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors.
November 2017, Bioorganic & medicinal chemistry letters,
Jiming Wang, and Xiangyu Zhang, and Jiangkun Yan, and Wei Li, and Qinwen Jiang, and Xinran Wang, and Dongmei Zhao, and Maosheng Cheng
Design, Synthesis, and Biological Evaluation of Quercetagetin Analogues as JNK1 Inhibitors.
November 2015, Chemistry (Weinheim an der Bergstrasse, Germany),
Copied contents to your clipboard!